ArticleCurrent medical science2026
Insulin Resistance Markers Predict New-Onset Diabetes in Middle-Aged and Elderly Adults with Cardiovascular-Kidney-Metabolic Syndrome.
Article in Current medical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
objectiveInsulin resistance (IR) is central to cardiovascular-kidney-metabolic (CKM) syndrome, but the best IR-related marker for identifying CKM patients at high risk of diabetes remains uncertain. This study examined associations between IR-related markers and new-onset diabetes and compared their predictive performance.
methodsWe analyzed 6,307 CKM participants from the China Health and Retirement Longitudinal Study (CHARLS) and 6,388 from the National Health and Nutrition Examination Survey (NHANES). Logistic regression and restricted cubic spline analyses were used to assess associations of triglyceride-glucose (TyG), TyG-body mass index (TyG-BMI), TyG-waist-to-height ratio (TyG-WHtR), metabolic score for IR (METS-IR), and estimated glucose disposal rate (eGDR) with diabetes. Subgroup analyses and receiver operating characteristic curves were employed to evaluate robustness and discrimination.
resultsOver 7 years, diabetes developed in 736 CHARLS participants (11.67%) and 1,451 NHANES participants (22.71%). Five IR-related markers were significantly associated with the risk of diabetes and demonstrated good predictive performance. Elevated levels of TyG, TyG-BMI, TyG-WHtR, and METS-IR, as well as lower levels of eGDR, were associated with increased diabetes risk (all P < 0.001). Most associations remained robust across subgroup analyses. Among the five markers, eGDR demonstrated the highest predictive performance in the NHANES cohort (AUC: 0.789; 95% CI: 0.776-0.802) and showed favorable predictive ability in the CHARLS cohort.
conclusionIR-related markers are significantly associated with the risk of diabetes in individuals with CKM syndrome and serve as reliable predictors of new-onset diabetes. Among these indicators, eGDR and TyG-WHtR were relatively reliable predictors, highlighting their potential as valuable tools for early diabetes screening.
Indexed as
Identifiers
42900339What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.